UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Neonatal herpes simplex virus infection: Clinical features and diagnosis

Author
Gail J Demmler-Harrison, MD
Section Editors
Sheldon L Kaplan, MD
Leonard E Weisman, MD
Deputy Editor
Carrie Armsby, MD, MPH

INTRODUCTION

Neonatal infection with herpes simplex virus (HSV) occurs in 1 out of every 3200 to 10,000 live births, causes serious morbidity and mortality, and leaves many survivors with permanent sequelae [1-4]. Despite this seemingly low prevalence, neonatal HSV accounts for 0.2 percent of neonatal hospitalizations and 0.6 percent of in-hospital neonatal deaths in the United States, and is associated with substantial healthcare resource utilization [5-8].

Since the discovery of neonatal HSV disease in the 1930s, important breakthroughs in understanding how HSV is transmitted to the fetus and neonate, molecular methods to diagnose HSV, and antiviral treatment strategies have improved diagnosis and treatment [5]. However, despite these advances, neonatal HSV remains a clinical challenge.

The clinical features and diagnosis of neonatal HSV infection will be reviewed below. The management, outcome, and prevention of neonatal HSV infection and non-neonatal HSV infections are discussed separately. (See "Neonatal herpes simplex virus infection: Management and prevention" and "Genital herpes simplex virus infection and pregnancy" and "Herpetic gingivostomatitis in young children" and "Clinical manifestations and diagnosis of herpes simplex virus type 1 infection".)

VIROLOGY

HSV is a member of the Herpesviridae family of viruses. It contains a double-stranded linear deoxyribonucleic acid (DNA) genome that consists of 150,000 base pairs that encode for more than 80 polypeptides, a capsid consisting of 162 capsomeres arranged in icosahedral symmetry that is covered by a tightly adherent membranous tegument, and an envelope consisting of 11 glycoproteins (gB, gC, gD, gE, gG, gH, gI, gJ, gK, gL, and gM), lipids, and polyamines that surrounds the viral nucleocapsid (picture 1) [5]. Like all Herpesviridae viruses, HSV shares the biological properties of latency and reactivation, which causes recurrent infections in the host.

HSV enters the human host through inoculation of oral, genital, or conjunctival mucosa or breaks in skin, infects the sensory nerve endings, and then transports via retrograde axonal flow to the dorsal root ganglia, where it remains for the life of the host. The fetus may be infected transplacentally or through retrograde spread through ruptured or seemingly intact membranes [5]. Latent virus is not susceptible to antiviral drugs, and infection (even after antiviral therapy) is lifelong. (See "Neonatal herpes simplex virus infection: Management and prevention", section on 'Outcome'.)

                               

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Tue Feb 16 00:00:00 GMT 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Brown ZA, Wald A, Morrow RA, et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003; 289:203.
  2. Flagg EW, Weinstock H. Incidence of neonatal herpes simplex virus infections in the United States, 2006. Pediatrics 2011; 127:e1.
  3. Roberts S. Herpes simplex virus: incidence of neonatal herpes simplex virus, maternal screening, management during pregnancy, and HIV. Curr Opin Obstet Gynecol 2009; 21:124.
  4. Mahnert N, Roberts SW, Laibl VR, et al. The incidence of neonatal herpes infection. Am J Obstet Gynecol 2007; 196:e55.
  5. Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev 2004; 17:1.
  6. Caviness AC, Demmler GJ, Swint JM, Cantor SB. Cost-effectiveness analysis of herpes simplex virus testing and treatment strategies in febrile neonates. Arch Pediatr Adolesc Med 2008; 162:665.
  7. Davis KL, Shah SS, Frank G, Eppes SC. Why are young infants tested for herpes simplex virus? Pediatr Emerg Care 2008; 24:673.
  8. Ambroggio L, Lorch SA, Mohamad Z, et al. Congenital anomalies and resource utilization in neonates infected with herpes simplex virus. Sex Transm Dis 2009; 36:680.
  9. Batra D, Davies P, Manktelow BN, Smith C. The incidence and presentation of neonatal herpes in a single UK tertiary centre, 2006-2013. Arch Dis Child 2014; 99:916.
  10. Jones CA, Raynes-Greenow C, Isaacs D, Neonatal HSV Study Investigators and Contributors to the Australian Paediatric Surveillance Unit. Population-based surveillance of neonatal herpes simplex virus infection in Australia, 1997-2011. Clin Infect Dis 2014; 59:525.
  11. Kimberlin DW. Herpes simplex virus infections of the newborn. Semin Perinatol 2007; 31:19.
  12. Caviness AC, Demmler GJ, Almendarez Y, Selwyn BJ. The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates. J Pediatr 2008; 153:164.
  13. Corey L, Wald A. Maternal and neonatal herpes simplex virus infections. N Engl J Med 2009; 361:1376.
  14. Caviness AC, Demmler GJ, Selwyn BJ. Clinical and laboratory features of neonatal herpes simplex virus infection: a case-control study. Pediatr Infect Dis J 2008; 27:425.
  15. Whitley R, Arvin A, Prober C, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 1991; 324:450.
  16. O'Riordan DP, Golden WC, Aucott SW. Herpes simplex virus infections in preterm infants. Pediatrics 2006; 118:e1612.
  17. Stanberry LR. Neonatal herpes in premature infants: a special problem. Pediatrics 2006; 118:2543.
  18. Fidler KJ, Pierce CM, Cubitt WD, et al. Could neonatal disseminated herpes simplex virus infections be treated earlier? J Infect 2004; 49:141.
  19. Knezevic A, Martic J, Stanojevic M, et al. Disseminated neonatal herpes caused by herpes simplex virus types 1 and 2. Emerg Infect Dis 2007; 13:302.
  20. Malik AN, Hildebrand GD, Sekhri R, Russell-Eggitt IM. Bilateral macular scars following intrauterine herpes simplex virus type 2 infection. J AAPOS 2008; 12:305.
  21. Koch LH, Fisher RG, Chen C, et al. Congenital herpes simplex virus infection: two unique cutaneous presentations associated with probable intrauterine transmission. J Am Acad Dermatol 2009; 60:312.
  22. Vasileiadis GT, Roukema HW, Romano W, et al. Intrauterine herpes simplex infection. Am J Perinatol 2003; 20:55.
  23. Marquez L, Levy ML, Munoz FM, Palazzi DL. A report of three cases and review of intrauterine herpes simplex virus infection. Pediatr Infect Dis J 2011; 30:153.
  24. Hyde SR, Giacoia GP. Congenital herpes infection: placental and umbilical cord findings. Obstet Gynecol 1993; 81:852.
  25. Peng J, Krause PJ, Kresch M. Neonatal herpes simplex virus infection after cesarean section with intact amniotic membranes. J Perinatol 1996; 16:397.
  26. Andersen RD. Herpes simplex virus infection of the neonatal respiratory tract. Am J Dis Child 1987; 141:274.
  27. Mascola L, Cable DC, Walsh P, Guinan ME. Neonatal herpes simplex virus death manifested as rapidly progressive pneumonia. Clin Pediatr (Phila) 1984; 23:400.
  28. Kimberlin DW, Lin CY, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001; 108:223.
  29. American Academy of Pediatrics. Herpes simplex. In: Red Book: 2015 Report of the Committee on Infectious Diseases, 30th ed, Kimberlin DW (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2015. p.432.
  30. Toth C, Harder S, Yager J. Neonatal herpes encephalitis: a case series and review of clinical presentation. Can J Neurol Sci 2003; 30:36.
  31. Corey L, Whitley RJ, Stone EF, Mohan K. Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet 1988; 1:1.
  32. Mizrahi EM, Tharp BR. A characteristic EEG pattern in neonatal herpes simplex encephalitis. Neurology 1982; 32:1215.
  33. Long SS. In defense of empiric acyclovir therapy in certain neonates. J Pediatr 2008; 153:157.
  34. Kimberlin DW. When should you initiate acyclovir therapy in a neonate? J Pediatr 2008; 153:155.
  35. Kimberlin DW, Gutierrez KM. Herpes simplex virus infections. In: Remington and Klein's infectious diseases of the fetus and newborn infant, 8th, Wilson CB, Nizet V, Maldonado YA, et al. (Eds), Saunders, Phildelphia, PA 2016. p.843.
  36. Riediger C, Sauer P, Matevossian E, et al. Herpes simplex virus sepsis and acute liver failure. Clin Transplant 2009; 23 Suppl 21:37.
  37. Meyer TA, Warner BW. Extracorporeal life support for the treatment of viral pneumonia: collective experience from the ELSO registry. Extracorporeal Life Support Organization. J Pediatr Surg 1997; 32:232.
  38. Filippine MM, Katz BZ. Neonatal herpes simplex virus infection presenting with fever alone. J Hum Virol 2001; 4:223.
  39. Cantey JB, Mejías A, Wallihan R, et al. Use of blood polymerase chain reaction testing for diagnosis of herpes simplex virus infection. J Pediatr 2012; 161:357.
  40. LaRocco MT. Evaluation of an enzyme-linked viral inducible system for the rapid detection of Herpes simplex virus. Eur J Clin Microbiol Infect Dis 2000; 19:233.
  41. Verano L, Michalski FJ. Comparison of a direct antigen enzyme immunoassay, Herpchek, with cell culture for detection of herpes simplex virus from clinical specimens. J Clin Microbiol 1995; 33:1378.
  42. Espy MJ, Uhl JR, Mitchell PS, et al. Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR. J Clin Microbiol 2000; 38:795.
  43. Slomka MJ, Emery L, Munday PE, et al. A comparison of PCR with virus isolation and direct antigen detection for diagnosis and typing of genital herpes. J Med Virol 1998; 55:177.
  44. Kimberlin DW, Lakeman FD, Arvin AM, et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1996; 174:1162.
  45. Malm G, Forsgren M. Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum. Arch Dis Child Fetal Neonatal Ed 1999; 81:F24.
  46. Kimura H, Futamura M, Kito H, et al. Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. J Infect Dis 1991; 164:289.
  47. Troendle-Atkins J, Demmler GJ, Buffone GJ. Rapid diagnosis of herpes simplex virus encephalitis by using the polymerase chain reaction. J Pediatr 1993; 123:376.
  48. Frenkel LM. Challenges in the diagnosis and management of neonatal herpes simplex virus encephalitis. Pediatrics 2005; 115:795.
  49. Mejías A, Bustos R, Ardura MI, et al. Persistence of herpes simplex virus DNA in cerebrospinal fluid of neonates with herpes simplex virus encephalitis. J Perinatol 2009; 29:290.
  50. Melvin AJ, Mohan KM, Schiffer JT, et al. Plasma and cerebrospinal fluid herpes simplex virus levels at diagnosis and outcome of neonatal infection. J Pediatr 2015; 166:827.
  51. Reina J, Saurina J, Fernandez-Baca V, et al. Evaluation of a direct immunofluorescence cytospin assay for the detection of herpes simplex virus in clinical samples. Eur J Clin Microbiol Infect Dis 1997; 16:851.
  52. Kurtz J, Anslow P. Infantile herpes simplex encephalitis: diagnostic features and differentiation from non-accidental injury. J Infect 2003; 46:12.